|Dr. Chi-Keon Loh||MD, CEO & Exec. Director||N/A||N/A||1974|
|Mr. Soon Teck Low||Group Chief Financial Officer||N/A||N/A||1965|
|Dr. Suet Wun Lim||Group Chief Operating Officer||N/A||N/A||1960|
|Ms. Penelope Koh||VP of Investor Relations||N/A||N/A||N/A|
|Ms. Teo Fay Lin||Group Chief HR Officer||N/A||N/A||1969|
IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide. The company operates in seven segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health, and PLife REIT. It provides primary care services, such as treatment of basic illnesses, routine check-ups, vaccination, and dental services. The company also offers secondary services, including specialist consultation, local surgeries, emergency care, laboratory, diagnostics, and acute treatment services; tertiary care services comprising specialist consultative care, advanced treatment or complex surgery, and inpatient care services; and quaternary care services consisting of complex surgeries and organ transplants. In addition, it provides a range of ancillary services, including diagnostics, analytical laboratory testing, therapeutic radiology, physiotherapy, occupational therapy, specialized exercise instruction, and integrated rehabilitation; and emergency assistance and transportation, and home services. Further, the company offers medical education and real estate investment trust services. As of February 27, 2019, it operated approximately 15,000 licensed beds across 82 hospitals in 11 countries worldwide. The company was formerly known as Integrated Healthcare Holdings Berhad and changed its name to IHH Healthcare Berhad in April 2012. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.
IHH Healthcare Berhad’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.